ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO897

A Pragmatic Randomized Clinical Trial: Twice-Weekly vs. Thrice-Weekly Incident Hemodialysis in Elderly Patients (PRIDE): Study Protocol

Session Information

  • Geriatric Nephrology
    November 03, 2023 | Location: Exhibit Hall, Pennsylvania Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Geriatric Nephrology

  • 1300 Geriatric Nephrology

Authors

  • Han, Miyeun, National Medical Center, Seoul, Korea (the Republic of)
  • Song, Sang Heon, Pusan National University, Kumjeong-ku, Korea (the Republic of)
  • Kwon, Soon hyo, Soonchunhyang University Hospital, Seoul, Korea (the Republic of)
Background

The optimal frequency for hemodialysis in older adults with end-stage kidney disease (ESKD) has not been established. This study aims to investigate whether a twice-weekly dialysis schedule using an incremental approach can reduce hospitalization rates in older adults with incident dialysis, compared with conventional thrice-weekly dialysis in South Korea.

Methods

We have designed a pragmatic randomized controlled trial to compare the effects of twice-weekly versus thrice-weekly hemodialysis in 428 ESKD (drop-out rate 20%) individuals aged 60 years or older with residual kidney function (urine output > 500 mL/day). The trial will be conducted across 18 referral hospital-based dialysis centers in Korea. Individual participants will be randomized to either the twice-weekly (with incremental approach) or thrice-weekly dialysis group and will be followed up for 24 months. The primary outcome of the study is the difference in all-cause hospitalization rates, while secondary outcomes include dialysis-specific hospitalization rates, mortality, quality of life, frailty, and cost-effectiveness. Participants have the flexibility to transfer to other dialysis centers as needed. The decision to increase dialysis frequency will be made by the treating physicians.

Results

The study is ongoing and will be completed in May 2026.

Conclusion

This study will provide valuable insights into the benefits and risks of twice-weekly dialysis with an incremental approach in older adults with residual kidney function compared to conventional dialysis treatment.

Funding

  • Government Support – Non-U.S.